GTX Corp and MNX Sign Three-Year Exclusive Contract to Provide GPS Tracking for Critical Medical and Bio-Pharmaceutical Shipments

LOS ANGELES, June 8, 2010 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), a leader in embedded GPS tracking location based services and MNX (Midnite Express), a worldwide specialty courier headquartered in Los Angeles with twenty-seven offices in eight countries, have entered into an exclusive three-year contract for GTX to deliver thousands of highly customized, industry-first GPS tracking devices along with the GTX Corp tracking platform to the shipping company.

As outlined in GTX's Form 8K filing, MNX has committed to buying and activating a minimum of 15,000 devices over the next three years and anticipates beginning deployment of 2,000 to 3,000 units sometime in the 3rd and 4th quarter of 2010. MNX will initially use them to track medical and bio-pharmaceutical shipments and eventually roll them out for all their high-value, sensitive shipments.

The critical and security-sensitive global transportation and logistics business is burgeoning and MNX is making the investment to become a leader by providing a fast, accurate and trackable "chain-of-custody" solution to this sector by integrating real time GPS tracking empowered by GTX Corp. This market represents one of MNX's fastest growing channels, and with the implementation of this technology, they hope to significantly increase their market share of this multibillion dollar vertical market.

"Real-time GPS tracking technology is game-changing for us and now we will be able to address any inquiry about the location and path of the thousands of critical shipments we manage for our customers," says Scott Cannon, CEO of MNX. "By enabling both our clients and airline partners to have full transparency regarding their shipments, MNX will offer a unique layer of service, security, temperature integrity and reliability. GTX is at the forefront of this technology and it offers a significant improvement over anything else available in the industry, and we are excited about the opportunity to work with them to pioneer its commercial use." In collaboration with prominent industry experts, this customized solution will greatly enhance the value proposition MNX already provides to the life sciences, medical and pharmaceutical transportation business.